Benjamin P. Levy, MD, Johns Hopkins Sidney Kimmel Cancer Center

Closing out their discussion on uncommon EGFR mutations in non–small cell lung cancer, Benjamin Levy, MD, and Estelamari Rodriguez, MD, MPH, consider how the treatment paradigm will continue to evolve.

Benjamin P. Levy, MD, discusses the importance of testing for KRAS mutations in lung cancer.